243 results on '"Poupart, Marc"'
Search Results
2. Prognostic impact of extranodal extension in resected head and neck squamous cell carcinomas in the era of postoperative chemoradiation: A retrospective monocentric study
3. Response rate with cetuximab used less than 3 months after immunotherapy (IO) for recurrent/metastatic head and neck squamous cell carcinomas (R/M HNSCC) compared to larger delay.
4. Comparison between exclusive (chemo)radiation and surgery or induction chemotherapy as first curative treatment for localized or locally advanced head and neck squamous cell carcinomas (L(A)-HNSCC): Sub-analysis of the EPOCKS study
5. Addictions, Social Deprivation and Cessation Failure in Head and Neck Squamous Cell Carcinoma Survivors
6. Salvage surgery for oropharyngeal squamous cell carcinomas: A retrospective study from 2005 to 2013
7. Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study
8. sj-docx-1-tmj-10.1177_03008916221078061 – Supplemental material for Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study
9. Allosteric N-acetamide-indole-6-carboxylic acid thumb pocket 1 inhibitors of hepatitis C virus NS5B polymerase--acylsulfonamides and acylsulfamides as carboxylic acid replacements
10. Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study
11. Pignat’s vertical partial laryngectomy with crico-hyoido-epiglotto-plasty
12. Supracricoid partial laryngectomy with crico-hyoido-epiglottoplasty: the rational behind larynx partial surgery
13. Pignat's vertical partial laryngectomy: surgical technique of crico-hyoido-epiglotto-plasty
14. Horizontal versus vertical partial laryngectomy: anatomic and functional differences
15. Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity
16. T1-T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study
17. Solid-phase synthesis of peptidomimetic inhibitors for the hepatitis C virus NS3 protease
18. Phosphorylation of the cohesin subunit Scc1 by Polo/Cdc5 kinase regulates sister chromatid separation in yeast
19. Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast
20. Stereoselective synthesis of renin inhibitor BILA 2157 BS
21. Binding Site Characterization and Resistance to a Class of Non-nucleoside Inhibitors of the Hepatitis C Virus NS5B Polymerase
22. Solid-phase synthesis of peptidyl trifluoromethyl ketones
23. Design and Synthesis of Macrocyclic Inhibitors of the Hepatitis C NS3 Protease
24. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
25. A convergent enantioselective approach involving new arrangements for the actuation of ring D cyclization
26. Expedient construction of the tetracyclic core by oxyanionic sigmatropy
27. Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumes
28. Cricoarytenoid arthritis in Sjögren’s syndrome
29. Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule
30. Discovery of non-peptidic P2–P3 butanediamide renin inhibitors with high oral efficacy
31. Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumes.
32. L’adénocarcinome cribriforme des glandes salivaires accessoires : une tumeur de description très récente. À propos d’une observation
33. Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors
34. Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
35. Neoadjuvant TP (Cisplatin-Docetaxel) for patients unfit to TPF (Cisplatin-Docetaxel-5FU) in locally advanced head and neck squamous cell cancer (LAHNSCC): an exploratory study on 14 patients
36. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma 
37. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma
38. Concise and Practical Asymmetric Synthesis of a Challenging Atropisomeric HIV Integrase Inhibitor
39. Indole 5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase with nanomolar potency in cell-based subgenomic replicons (part 2): Central amino acid linker and right-hand-side SAR studies
40. From benzimidazole to indole-5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase. Part 1: Indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons
41. N-Acetamideindolecarboxylic acid allosteric ‘finger-loop’ inhibitors of the hepatitis C virus NS5B polymerase: discovery and initial optimization studies
42. Discovery of BI 207524, an Indole Diamide NS5B Thumb Pocket 1 Inhibitor with Improved Potency for the Potential Treatment of Chronic Hepatitis C Virus Infection
43. A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy
44. Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV)
45. An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents
46. Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
47. Modified DCF (mDCF, docetaxel cisplatin 5FU) for patients with locally advanced squamous cell carcinoma of the head and neck (LASCCHN) unfit to DCF: A retrospective study.
48. Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast
49. Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1
50. Massive Multinodular Head and Neck Recurrence of Parotid Gland Pleomorphic Adenoma: A Case Report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.